Correction: GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma (Bone Marrow Transplantation, (2021), 56, 1, (155-166), 10.1038/s41409-020-00996-y)

The ATL Working Group of the Japanese Society for Hematopoietic Cell Transplantation

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Correction: GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma (Bone Marrow Transplantation, (2021), 56, 1, (155-166), 10.1038/s41409-020-00996-y)'. Together they form a unique fingerprint.

Medicine & Life Sciences